Growing EV Market The increasing focus on extracellular vesicle EV research for clinical diagnostics and therapeutics presents significant sales opportunities for Izon’s scalable isolation solutions and high-resolution characterization technologies, especially as demand rises globally.

Recent Collaborations Strategic partnerships like the collaboration with Atlantis Bioscience and Agarose Bead Technologies indicate ongoing efforts to expand product applications and research adoption, creating avenues for additional sales of specialized columns and automation instrumentation.

Product Innovation The launch of optimized qEV columns, including Gen 2 and dedicated 1 mL formats, demonstrates ongoing product development that can address diverse research needs, opening up opportunities for upselling and cross-selling advanced chromatography solutions.

Global Presence With offices in New Zealand, France, and the US, Izon’s international reach positions it to target key regions actively engaged in nanomedicine and EV research, enabling tailored outreach and partnerships in high-growth markets.

Funding and Revenue Despite a modest revenue footprint and limited funding, Izon’s innovative product pipeline and recent breakthroughs offer potential for expansion and increased sales, especially by targeting emerging biotech and academic institutions invested in EV research.